missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. FATE1 Antibody, Novus Biologicals™

FATE1 Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody

£381.00

Specifications

Antigen FATE1
Applications Western Blot
Classification Polyclonal
Conjugate Unconjugated
Host Species Rabbit
View More Specs

Products 1
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18219575
View Documents
missing translation for 'viewProductCertificates'
Novus Biologicals
NBP1-79779 		100 μL
£381.00
100µL
View alternative products
Save Up to  »
Please to purchase this item. Need a web account? Register with us today!
Description

Description

FATE1 Polyclonal specifically detects FATE1 in Human samples. It is validated for Western Blot.
Specifications

Specifications

FATE1
Polyclonal
Rabbit
Human
Cancer/testis antigen 43, CT43BJ-HCC-2 antigen, FATEfetal and adult testis expressed transcript protein, fetal and adult testis expressed 1, fetal and adult testis-expressed transcript protein, Tumor antigen BJ-HCC-2
FATE1
IgG
21 kDa
Western Blot
Unconjugated
RUO
NP_149076
89885
Synthetic peptide directed towards the N terminal of human FATE1The immunogen for this antibody is FATE1. Peptide sequence PNTKAEMEMSLAEELNHGRQGENQEHLVIAEMMELGSRSRGASQKKQKLE.
Primary
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.